NfL Promising Biomarker for Predicting Tecfidera Response

NfL Promising Biomarker for Predicting Tecfidera Response

295655

NfL Promising Biomarker for Predicting Tecfidera Response

Low levels of serum neurofilament light chains (sNfL) prior to treatment predicts an optimal response to Tecfidera (dimethyl fumarate) and reduced immune cell overactivity in multiple sclerosis (MS) patients, a study reports. The investigators noted the importance of identifying patients likely to have an optimal response to Tecfidera and dimethyl fumarate generics “to avoid potential relapses or disability progression in suboptimal responders.” The study, “Low serum neurofilament light chain values identify optimal responders to dimethyl…

You must be logged in to read/download the full post.